Paper Details

  1. Home
  2. Paper Details

Pentoxifylline for intermittent claudication.

Author: Abdel-HadiMohammed, BroderickCathryn, ForsterRachel, SalhiyyahKareem

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Intermittent claudication (IC) is a symptom of peripheral artery disease (PAD) that causes pain in the legs during walking. Pentoxifylline is a drug that is used to treat IC by improving blood flow to the legs. This review examined the evidence for the effectiveness of pentoxifylline in the treatment of IC. The review found that the evidence for the effectiveness of pentoxifylline is mixed. Some studies have shown that pentoxifylline is effective in treating IC, while others have not.
Paper Details　
Original Abstract of the Article :
Intermittent claudication (IC) is a symptom of peripheral arterial disease (PAD) and is associated with high morbidity and mortality. Pentoxifylline, one of many drugs used to treat IC, acts by decreasing blood viscosity, improving erythrocyte flexibility, and promoting microcirculatory flow and tis...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094235/

データ提供：米国国立医学図書館（NLM）

Pentoxifylline for Intermittent Claudication: A Complex Treatment

Imagine a condition where your leg muscles cramp up and hurt, making walking difficult. This study examined the effectiveness of pentoxifylline, a drug used to treat intermittent claudication (IC), a symptom of peripheral arterial disease (PAD). The authors reviewed a vast body of research on pentoxifylline's use in treating IC, analyzing the results of various studies to assess its effectiveness and potential side effects. The study aimed to provide a comprehensive overview of pentoxifylline's role in managing IC.

Variable Effectiveness of Pentoxifylline in Treating IC

The study found that the effectiveness of pentoxifylline in treating IC is variable, with some studies showing positive results and others showing less clear benefits. The authors highlighted the need for further research to better understand the role of pentoxifylline in managing IC. They emphasized the importance of individualizing treatment approaches and considering other factors that might influence the effectiveness of pentoxifylline.

Navigating IC Treatment: A Collaborative Approach

This study reminds us that there is no one-size-fits-all solution for treating IC. It highlights the importance of working closely with your healthcare provider to explore different treatment options and develop a personalized plan that addresses your specific needs. Just as a camel relies on its instincts to navigate a challenging desert environment, it's essential to be proactive in managing your health and to seek expert guidance when needed.

Dr.Camel's Conclusion

This review provides a comprehensive overview of the complex relationship between pentoxifylline and intermittent claudication. It highlights the importance of ongoing research to better understand the effectiveness of this medication and to explore alternative treatment options. By working closely with healthcare providers, individuals with IC can strive for the best possible outcomes and navigate the challenges of this condition.

Date :
  1. Date Completed 2020-11-13
  2. Date Revised 2022-09-19
Further Info :

Pubmed ID

33063850

DOI: Digital Object Identifier

PMC8094235

Related Literature

Article Analysis
・Side Effects of pentoxifylline
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.